KR850002478A - 2-(n-피롤리디노)-3-이소부톡시-n-치환된 페닐-n-벤질-프로필아민의 제조방법 - Google Patents
2-(n-피롤리디노)-3-이소부톡시-n-치환된 페닐-n-벤질-프로필아민의 제조방법 Download PDFInfo
- Publication number
- KR850002478A KR850002478A KR1019840005947A KR840005947A KR850002478A KR 850002478 A KR850002478 A KR 850002478A KR 1019840005947 A KR1019840005947 A KR 1019840005947A KR 840005947 A KR840005947 A KR 840005947A KR 850002478 A KR850002478 A KR 850002478A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- preparing
- general formula
- formula
- pyrrolidino
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 2
- WJZNJZWXOFGUFC-UHFFFAOYSA-N n-benzyl-n-propylaniline Chemical class C=1C=CC=CC=1N(CCC)CC1=CC=CC=C1 WJZNJZWXOFGUFC-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 7
- 239000002253 acid Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- -1 alkali metal amide Chemical class 0.000 claims 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 claims 1
- 150000008046 alkali metal hydrides Chemical class 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000005699 methyleneoxy group Chemical group [H]C([H])([*:1])O[*:2] 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (3)
- 하기 일반식〔A〕 화합물 또는 그것의 산부가염을 일반식〔B〕화합물 또는 그것의 산부가염과 반응시키고 Q가 산소일때는 산출된 카르보닐함유 화합물을 환원시킨후, 선택적으로 약학적 유용산 부가염으로 전환시키는 것을 특징으로 하는 하기 일반식(I) 화합물의 제조방법.여기에서, X는 할로겐, 수산기, 알킬기, 트리플루오로메틸 또는 메틸렌옥시기중의 하나 또는 두개의 기이며, Q는 산소 또는 두개의 수소원자(2H)를 Hal은 할로겐, 바람직하게는 염소를 나타낸다.
- 제1항에 있어서, 일반식〔B〕화합물을 알카리금속 하이드라이드 또는 알카리금속 아미드로 금속화하여 일반식〔A〕와 〔B〕의 화합물 반응을 촉진시킴을 특징으로 하는 제조방법.
- 일반식〔I〕화합물을 활성성분으로 하며 그 활성성분의 양을 1내지 15mg/kg 체중의 일일 투여분으로 투여될 수 있도록 포함하는 약학적 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8315367 | 1983-09-27 | ||
FR8315367 | 1983-09-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR850002478A true KR850002478A (ko) | 1985-05-13 |
KR910003711B1 KR910003711B1 (ko) | 1991-06-08 |
Family
ID=9292587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019840005947A KR910003711B1 (ko) | 1983-09-27 | 1984-09-27 | 2-(n-피롤리디노)-3-이소부톡시-n-치환된 페닐-n-벤질-프로필아민의 제조방법 |
Country Status (15)
Country | Link |
---|---|
US (1) | US4645778A (ko) |
EP (1) | EP0138684B1 (ko) |
JP (1) | JPS6092279A (ko) |
KR (1) | KR910003711B1 (ko) |
AT (1) | ATE42100T1 (ko) |
AU (1) | AU569326B2 (ko) |
CA (1) | CA1235417A (ko) |
DE (1) | DE3477664D1 (ko) |
DK (1) | DK156396C (ko) |
ES (1) | ES8602723A1 (ko) |
FI (1) | FI78081C (ko) |
GR (1) | GR80481B (ko) |
HU (1) | HU192589B (ko) |
PT (1) | PT79273B (ko) |
ZA (1) | ZA847508B (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4727072A (en) * | 1986-02-12 | 1988-02-23 | Mcneilab, Inc. | 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents |
US4758563A (en) * | 1986-02-12 | 1988-07-19 | Mcneilab, Inc. | 3-alkoxy-2-aminopropyamines, cardiovascular compositions and use |
DE3726633A1 (de) * | 1987-08-11 | 1989-02-23 | Boehringer Mannheim Gmbh | Neue 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten |
DE3726632A1 (de) * | 1987-08-11 | 1989-05-18 | Boehringer Mannheim Gmbh | 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten |
US4888335A (en) * | 1988-07-25 | 1989-12-19 | Mcneilab, Inc. | 3-alkoxy-2-aminopropyl heterocyclic amines and their use as cardiovascular agents |
US5185362A (en) * | 1988-09-14 | 1993-02-09 | Mcneilab, Inc. | Diphenylamine cardiovascular agents, compositions and use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US30577A (en) * | 1860-11-06 | Truss-bridge | ||
BE795735A (fr) * | 1972-03-06 | 1973-06-18 | Cerm Cent Europ Rech Mauvernay | Nouvelles ethylenediamines substituees a activite cardiovasculaire |
FR2378024A1 (fr) * | 1977-01-25 | 1978-08-18 | Cerm Cent Europ Rech Mauvernay | Nouvelle propylamine substituee, obtention et application |
GB2087233A (en) * | 1980-09-30 | 1982-05-26 | Akzo Nv | Pharmaceutical compositions containing n-aryl ethanamines having anti-atherothrombosclerotic activity |
FR2504925A1 (en) * | 1981-05-04 | 1982-11-05 | Cerm Cent Europ Rech Mauvernay | N-2-amino 3-alkoxy or phenoxy-propyl urea and thiourea derivs. - are cardiovascular agents esp. used to treat arrhythmia |
GB8330197D0 (en) * | 1983-11-11 | 1983-12-21 | Akzo Nv | Ether of n-propanolamine derivative |
-
1984
- 1984-09-21 DK DK451884A patent/DK156396C/da not_active IP Right Cessation
- 1984-09-24 ZA ZA847508A patent/ZA847508B/xx unknown
- 1984-09-26 JP JP59201418A patent/JPS6092279A/ja active Granted
- 1984-09-26 EP EP84401919A patent/EP0138684B1/fr not_active Expired
- 1984-09-26 HU HU843653A patent/HU192589B/hu not_active IP Right Cessation
- 1984-09-26 AU AU33540/84A patent/AU569326B2/en not_active Ceased
- 1984-09-26 AT AT84401919T patent/ATE42100T1/de not_active IP Right Cessation
- 1984-09-26 ES ES536264A patent/ES8602723A1/es not_active Expired
- 1984-09-26 CA CA000464017A patent/CA1235417A/en not_active Expired
- 1984-09-26 DE DE8484401919T patent/DE3477664D1/de not_active Expired
- 1984-09-26 GR GR80481A patent/GR80481B/el unknown
- 1984-09-26 FI FI843785A patent/FI78081C/fi not_active IP Right Cessation
- 1984-09-27 KR KR1019840005947A patent/KR910003711B1/ko active IP Right Grant
- 1984-09-27 US US06/654,921 patent/US4645778A/en not_active Expired - Fee Related
- 1984-09-27 PT PT79273A patent/PT79273B/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH0336836B2 (ko) | 1991-06-03 |
US4645778A (en) | 1987-02-24 |
AU3354084A (en) | 1985-04-04 |
FI78081C (fi) | 1989-06-12 |
ES536264A0 (es) | 1985-12-01 |
CA1235417A (en) | 1988-04-19 |
DK156396C (da) | 1990-01-08 |
JPS6092279A (ja) | 1985-05-23 |
KR910003711B1 (ko) | 1991-06-08 |
FI843785A0 (fi) | 1984-09-26 |
DK451884D0 (da) | 1984-09-21 |
AU569326B2 (en) | 1988-01-28 |
DK156396B (da) | 1989-08-14 |
PT79273A (en) | 1984-10-01 |
HU192589B (en) | 1987-06-29 |
EP0138684A2 (fr) | 1985-04-24 |
GR80481B (en) | 1985-01-28 |
PT79273B (en) | 1986-08-28 |
ATE42100T1 (de) | 1989-04-15 |
EP0138684B1 (fr) | 1989-04-12 |
DE3477664D1 (en) | 1989-05-18 |
EP0138684A3 (en) | 1985-06-19 |
FI78081B (fi) | 1989-02-28 |
HUT36469A (en) | 1985-09-30 |
DK451884A (da) | 1985-03-28 |
FI843785L (fi) | 1985-03-28 |
ES8602723A1 (es) | 1985-12-01 |
ZA847508B (en) | 1985-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR840008014A (ko) | 오메프라졸염의 제조방법 | |
DE3271269D1 (en) | Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same | |
IL85988A (en) | 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them | |
DE3160036D1 (en) | Substituted imidazoles, their preparation and pharmaceutical compositions containing the same | |
ES8503667A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina. | |
ES2060547A1 (es) | Mejoras en el objeto de la patente de invencion n/ 9201158 que se refiere a "procedimiento de obtencion de nuevos derivados de la 4-bencilpiperidina". | |
ES482472A1 (es) | Procedimiento para la preparacion de isoquinoleinas. | |
KR850002478A (ko) | 2-(n-피롤리디노)-3-이소부톡시-n-치환된 페닐-n-벤질-프로필아민의 제조방법 | |
KR890014435A (ko) | 페녹시알킬카복실산 유도체 및 이의 제조방법 | |
ES8400428A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-piperazino primidina. | |
ES8106289A1 (es) | Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol | |
KR910000647A (ko) | 나프틸아미노-및 나프틸옥시- 피리딘아민 및 관련된 화합물, 이의 제조방법 및 이의 피부소염제로서의 용도 | |
KR920007995A (ko) | 벤즈아미드 유도체 | |
ES8700242A1 (es) | Un procedimiento para preparar un derivado de dihidropirida-zinona | |
ATE18906T1 (de) | Allyloxy- und allylthio-2,3,4,5-tetrahydro-1h-3- benzazepine. | |
KR890003692A (ko) | 1.2.5.6- 테트라히드로피리딘-3-카르복스알데히드의 옥심유도체, 이들의 제조방법, 약제로서의 이들의 용도 및 이들을 함유하는 조성물 | |
ES8500953A1 (es) | Procedimiento para preparar derivados de tieno-tiazol | |
KR890008148A (ko) | 새로운 세파로스포린 화합물 및 항균제 | |
EP0073345A3 (en) | Sydnonimine derivatives, process for production thereof, and use thereof | |
KR920003970A (ko) | 혈중 요산 함량의 강하 방법 | |
KR850003382A (ko) | 디아릴인단-1,3-디온의 제조방법 | |
KR910000648A (ko) | 페녹시피리딘아민 및 이의 유도체, 제조방법 및 약제로서의 용도 | |
ES2007784A6 (es) | Procedimiento para la preparacion de derivados de 1-alquil-ergolinil-tiourea> | |
ES8407482A1 (es) | Un procedimiento para la preparacion de nuevos derivados de acidos alquiloxazolilaceticos. | |
KR900011757A (ko) | 피리디늄 니트레이트, 그의 제조방법 및 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
NORF | Unpaid initial registration fee |